1 resultado para Drug Reporting-system
em Dalarna University College Electronic Archive
Filtro por publicador
- Academic Research Repository at Institute of Developing Economies (2)
- Acceda, el repositorio institucional de la Universidad de Las Palmas de Gran Canaria. España (1)
- AMS Tesi di Dottorato - Alm@DL - Università di Bologna (10)
- AMS Tesi di Laurea - Alm@DL - Università di Bologna (1)
- Applied Math and Science Education Repository - Washington - USA (1)
- Aquatic Commons (4)
- ArchiMeD - Elektronische Publikationen der Universität Mainz - Alemanha (7)
- Archivo Digital para la Docencia y la Investigación - Repositorio Institucional de la Universidad del País Vasco (1)
- Aston University Research Archive (49)
- B-Digital - Universidade Fernando Pessoa - Portugal (1)
- Biblioteca de Teses e Dissertações da USP (2)
- Biblioteca Digital da Produção Intelectual da Universidade de São Paulo (13)
- Biblioteca Digital da Produção Intelectual da Universidade de São Paulo (BDPI/USP) (7)
- Biblioteca Digital de Teses e Dissertações Eletrônicas da UERJ (1)
- Bioline International (4)
- BORIS: Bern Open Repository and Information System - Berna - Suiça (66)
- Bucknell University Digital Commons - Pensilvania - USA (3)
- Bulgarian Digital Mathematics Library at IMI-BAS (2)
- CaltechTHESIS (3)
- Cambridge University Engineering Department Publications Database (1)
- CentAUR: Central Archive University of Reading - UK (15)
- Chinese Academy of Sciences Institutional Repositories Grid Portal (21)
- Cochin University of Science & Technology (CUSAT), India (3)
- Coffee Science - Universidade Federal de Lavras (1)
- Collection Of Biostatistics Research Archive (1)
- CORA - Cork Open Research Archive - University College Cork - Ireland (2)
- Dalarna University College Electronic Archive (1)
- DI-fusion - The institutional repository of Université Libre de Bruxelles (2)
- Digital Archives@Colby (1)
- Digital Commons - Michigan Tech (2)
- Digital Commons @ DU | University of Denver Research (1)
- Digital Commons at Florida International University (16)
- DigitalCommons@The Texas Medical Center (31)
- Doria (National Library of Finland DSpace Services) - National Library of Finland, Finland (3)
- DRUM (Digital Repository at the University of Maryland) (3)
- Duke University (8)
- eResearch Archive - Queensland Department of Agriculture; Fisheries and Forestry (5)
- FUNDAJ - Fundação Joaquim Nabuco (2)
- Glasgow Theses Service (1)
- Greenwich Academic Literature Archive - UK (4)
- Helda - Digital Repository of University of Helsinki (9)
- Indian Institute of Science - Bangalore - Índia (26)
- Institutional Repository of Leibniz University Hannover (1)
- Instituto Nacional de Saúde de Portugal (1)
- Instituto Politécnico de Viseu (2)
- Instituto Politécnico do Porto, Portugal (4)
- Iowa Publications Online (IPO) - State Library, State of Iowa (Iowa), United States (10)
- National Center for Biotechnology Information - NCBI (9)
- Portal de Revistas Científicas Complutenses - Espanha (1)
- QSpace: Queen's University - Canada (2)
- QUB Research Portal - Research Directory and Institutional Repository for Queen's University Belfast (53)
- Queensland University of Technology - ePrints Archive (93)
- RCAAP - Repositório Científico de Acesso Aberto de Portugal (1)
- Repositorio de la Universidad de Cuenca (1)
- Repositório Institucional da Universidade de Brasília (1)
- Repositório Institucional UNESP - Universidade Estadual Paulista "Julio de Mesquita Filho" (120)
- Research Open Access Repository of the University of East London. (1)
- RUN (Repositório da Universidade Nova de Lisboa) - FCT (Faculdade de Cienecias e Technologia), Universidade Nova de Lisboa (UNL), Portugal (4)
- School of Medicine, Washington University, United States (1)
- SerWisS - Server für Wissenschaftliche Schriften der Fachhochschule Hannover (1)
- South Carolina State Documents Depository (2)
- The Scholarly Commons | School of Hotel Administration; Cornell University Research (1)
- Universidad de Alicante (1)
- Universidad del Rosario, Colombia (10)
- Universidad Politécnica de Madrid (1)
- Universidade de Lisboa - Repositório Aberto (4)
- Universidade Estadual Paulista "Júlio de Mesquita Filho" (UNESP) (5)
- Universidade Federal do Rio Grande do Norte (UFRN) (8)
- Universidade Técnica de Lisboa (1)
- Universita di Parma (1)
- Universitätsbibliothek Kassel, Universität Kassel, Germany (1)
- Université de Lausanne, Switzerland (8)
- Université de Montréal (1)
- Université de Montréal, Canada (6)
- University of Connecticut - USA (1)
- University of Innsbruck Digital Library - Austria (1)
- University of Michigan (66)
- University of Queensland eSpace - Australia (45)
- University of Washington (7)
- WestminsterResearch - UK (1)
Resumo:
This thesis is an application of the Almost Ideal Demand System approach of Deaton and Muellbauer,1980, for a particular pharmaceutical, Citalopram, in which GORMAN´s (1971) multi-stage budgeting approach is applied basically since it is one of the most useful approach in estimating demand for differentiated products. Citalopram is an antidepressant drug that is used in the treatment of major depression. As for most other pharmaceuticals whose the patent has expired, there exist branded and generic versions of Citalopram. This paper is aimed to define its demand system with two stage models for the branded version and five generic versions, and to show whether generic versions are able to compete with the branded version. I calculated the own price elasticities, and it made me possible to compare and make a conclusion about the consumers’ choices over the brand and generic drugs. Even though the models need for being developed with some additional variables, estimation results of models and uncompensated price elasticities indicated that the branded version has still power in the market, and generics are able to compete with lower prices. One important point that has to be taken into consideration is that the Swedish pharmaceutical market faced a reform on October 1, 2002, that aims to make consumer better informed about the price and decrease the overall expenditures for pharmaceuticals. Since there were not significantly enough generic sales to take into calculation before the reform, my paper covers sales after the reform.